Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.77%
#4 aPriori aPriori +120.78%
#5 Bedrock Bedrock +76.11%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.13%
#9 COTI COTI +25.33%
#10 Nillion Nillion +24.72%
Coin of the day
Wrapped One Wrapped One
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Rang in aandelen #88
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$47.55
Marktkapitalisatie
$211.25B
Verandering (1 dag)
-2.51%
Verandering (1 jaar)
-5.18%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)

Categorie

Healthcare
P/S-ratio voor Novo Nordisk A/S (NOVO-B)
P/S-ratio op February 2026 TTM: 4.47
Volgens de meest recente financiële rapporten en aandelenkoers van Novo Nordisk A/S is de huidige P/S-ratio (TTM) 4.47. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Novo Nordisk A/S van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 235.27%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 41.28%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 58.02%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 4.33%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 9.81%
US